Your browser doesn't support javascript.
loading
Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi-institutional analysis.
Hulin, Maud; Audigé, Victor; Baghli, Adnan; Larré, Stéphane; Eschwege, Pascal; Bensalah, Karim; Khene, Zine-Eddine.
Affiliation
  • Hulin M; Department of Urology, Reims University Hospital, Reims, France. maud.hulin@orange.fr.
  • Audigé V; Department of Urology, Reims University Hospital, Reims, France.
  • Baghli A; Department of Urology, Nancy University Hospital, Nancy, France.
  • Larré S; Department of Urology, Reims University Hospital, Reims, France.
  • Eschwege P; Department of Urology, Nancy University Hospital, Nancy, France.
  • Bensalah K; Department of Urology, Rennes University Hospital, Rennes, France.
  • Khene ZE; Department of Urology, Rennes University Hospital, Rennes, France.
Int J Clin Oncol ; 2024 Jul 09.
Article in En | MEDLINE | ID: mdl-38980558
ABSTRACT

INTRODUCTION:

The aim of the study was to determine the impact of positive surgical margins (PSM) after PN on very long-term recurrence in a contemporary cohort.

METHODS:

Patients who underwent PN for a localized renal tumour were included. Patients were stratified according to the presence of PSM. Data on patients' characteristics, the tumour, the peri- and postoperative events were collected. Disease-free survival (DFS) and overall survival (OS) were assessed by the Kaplan-Meier method and compared by the log-rank test. Sensitivity analyses using weighted propensity score analysis was performed to account for potential selection biases arising from the nonrandom allocation of patients to different groups.

RESULTS:

A total of 1115 patients were included in the study. The incidence of PSM was 5.4% (n = 61). The median follow-up time was 51 months for the PSM group and 61 months for the NSM group (p = 0.31). Recurrence rates were significantly higher in the PSM group (13%, n = 8) compared to the NSM group (7%, n = 73) (p = 0.05). This resulted in a significant reduction in DFS in the PSM group (p = 0.004), particularly pronounced in patients with clear cell renal cell carcinoma. Additionally, OS was significantly lower in the PSM group (p < 0.01). Propensity score analysis confirmed a decrease in DFS for the PSM group (p = 0.05), while there was no significant difference in OS between the two groups (p = 0.49).

CONCLUSION:

In this retrospective multicenter study, PSM impact on oncological outcomes, increasing recurrence, but no difference in OS was observed post-adjustment for biases.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: France